69 related articles for article (PubMed ID: 19944070)
21. Identification of a novel proapoptotic function of resveratrol in fat cells: SIRT1-independent sensitization to TRAIL-induced apoptosis.
Mader I; Wabitsch M; Debatin KM; Fischer-Posovszky P; Fulda S
FASEB J; 2010 Jun; 24(6):1997-2009. PubMed ID: 20097879
[TBL] [Abstract][Full Text] [Related]
22. Evidence for a common mechanism of SIRT1 regulation by allosteric activators.
Hubbard BP; Gomes AP; Dai H; Li J; Case AW; Considine T; Riera TV; Lee JE; E SY; Lamming DW; Pentelute BL; Schuman ER; Stevens LA; Ling AJ; Armour SM; Michan S; Zhao H; Jiang Y; Sweitzer SM; Blum CA; Disch JS; Ng PY; Howitz KT; Rolo AP; Hamuro Y; Moss J; Perni RB; Ellis JL; Vlasuk GP; Sinclair DA
Science; 2013 Mar; 339(6124):1216-9. PubMed ID: 23471411
[TBL] [Abstract][Full Text] [Related]
23. Genetic analysis of the SIRT1 gene promoter in ventricular septal defects.
Shan J; Pang S; Wanyan H; Xie W; Qin X; Yan B
Biochem Biophys Res Commun; 2012 Sep; 425(4):741-5. PubMed ID: 22885181
[TBL] [Abstract][Full Text] [Related]
24. Genetic analysis of SIRT1 gene promoter in sporadic Parkinson's disease.
Zhang A; Wang H; Qin X; Pang S; Yan B
Biochem Biophys Res Commun; 2012 Jun; 422(4):693-6. PubMed ID: 22613205
[TBL] [Abstract][Full Text] [Related]
25. Probing the mechanism of SIRT1 activation by a 1,4-dihydropyridine.
Manna D; Bhuyan R; Ghosh R
J Mol Model; 2018 Nov; 24(12):340. PubMed ID: 30448921
[TBL] [Abstract][Full Text] [Related]
26. Sirt1 interacts with transducin-like enhancer of split-1 to inhibit nuclear factor kappaB-mediated transcription.
Ghosh HS; Spencer JV; Ng B; McBurney MW; Robbins PD
Biochem J; 2007 Nov; 408(1):105-11. PubMed ID: 17680780
[TBL] [Abstract][Full Text] [Related]
27. Sirt1 deacetylates c-Myc and promotes c-Myc/Max association.
Mao B; Zhao G; Lv X; Chen HZ; Xue Z; Yang B; Liu DP; Liang CC
Int J Biochem Cell Biol; 2011 Nov; 43(11):1573-81. PubMed ID: 21807113
[TBL] [Abstract][Full Text] [Related]
28. Protein deacetylase SIRT1 in the cytoplasm promotes nerve growth factor-induced neurite outgrowth in PC12 cells.
Sugino T; Maruyama M; Tanno M; Kuno A; Houkin K; Horio Y
FEBS Lett; 2010 Jul; 584(13):2821-6. PubMed ID: 20434449
[TBL] [Abstract][Full Text] [Related]
29. Structure and substrate binding properties of cobB, a Sir2 homolog protein deacetylase from Escherichia coli.
Zhao K; Chai X; Marmorstein R
J Mol Biol; 2004 Mar; 337(3):731-41. PubMed ID: 15019790
[TBL] [Abstract][Full Text] [Related]
30. SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells.
Miyazaki R; Ichiki T; Hashimoto T; Inanaga K; Imayama I; Sadoshima J; Sunagawa K
Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1263-9. PubMed ID: 18420994
[TBL] [Abstract][Full Text] [Related]
31. Involvement of the p65/RelA subunit of NF-kappaB in TNF-alpha-induced SIRT1 expression in vascular smooth muscle cells.
Zhang HN; Li L; Gao P; Chen HZ; Zhang R; Wei YS; Liu DP; Liang CC
Biochem Biophys Res Commun; 2010 Jul; 397(3):569-75. PubMed ID: 20617556
[TBL] [Abstract][Full Text] [Related]
32. SIRT1 regulates the histone methyl-transferase SUV39H1 during heterochromatin formation.
Vaquero A; Scher M; Erdjument-Bromage H; Tempst P; Serrano L; Reinberg D
Nature; 2007 Nov; 450(7168):440-4. PubMed ID: 18004385
[TBL] [Abstract][Full Text] [Related]
33. Catalytic-independent neuroprotection by SIRT1 is mediated through interaction with HDAC1.
Pfister JA; Ma C; D'Mello SR
PLoS One; 2019; 14(4):e0215208. PubMed ID: 30973934
[TBL] [Abstract][Full Text] [Related]
34. Peptide switch is essential for Sirt1 deacetylase activity.
Kang H; Suh JY; Jung YS; Jung JW; Kim MK; Chung JH
Mol Cell; 2011 Oct; 44(2):203-13. PubMed ID: 22017869
[TBL] [Abstract][Full Text] [Related]
35. Structural analysis of the inhibitory effects of polyphenols, (+)-hopeaphenol and (-)-isohopeaphenol, on human SIRT1.
Loisruangsin A; Hikita K; Seto N; Niwa M; Takaya Y; Kaneda N
Biofactors; 2019 Mar; 45(2):253-258. PubMed ID: 30537158
[TBL] [Abstract][Full Text] [Related]
36. Dissecting the roles of the N- and C-flanking residues of acetyllysine substrates for SIRT1 activity.
Meledin R; Brik A; Aharoni A
Chembiochem; 2013 Mar; 14(5):577-81. PubMed ID: 23426869
[TBL] [Abstract][Full Text] [Related]
37. Molecular and Cellular Characterization of SIRT1 Allosteric Activators.
Schultz MB; Rinaldi C; Lu Y; Amorim JA; Sinclair DA
Methods Mol Biol; 2019; 1983():133-149. PubMed ID: 31087296
[TBL] [Abstract][Full Text] [Related]
38. Multifaceted Modulation of SIRT1 in Cancer and Inflammation.
Yang H; Bi Y; Xue L; Wang J; Lu Y; Zhang Z; Chen X; Chu Y; Yang R; Wang R; Liu G
Crit Rev Oncog; 2015; 20(1-2):49-64. PubMed ID: 25746104
[TBL] [Abstract][Full Text] [Related]
39. Structural and functional analysis of human SIRT1.
Davenport AM; Huber FM; Hoelz A
J Mol Biol; 2014 Feb; 426(3):526-41. PubMed ID: 24120939
[TBL] [Abstract][Full Text] [Related]
40. Crystallographic structure of a small molecule SIRT1 activator-enzyme complex.
Dai H; Case AW; Riera TV; Considine T; Lee JE; Hamuro Y; Zhao H; Jiang Y; Sweitzer SM; Pietrak B; Schwartz B; Blum CA; Disch JS; Caldwell R; Szczepankiewicz B; Oalmann C; Yee Ng P; White BH; Casaubon R; Narayan R; Koppetsch K; Bourbonais F; Wu B; Wang J; Qian D; Jiang F; Mao C; Wang M; Hu E; Wu JC; Perni RB; Vlasuk GP; Ellis JL
Nat Commun; 2015 Jul; 6():7645. PubMed ID: 26134520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
